|
|
 | | | |
- close
- close
- close
- close
These excerpts taken from the THRX 10-K filed Feb 27, 2009. Cash and Cash Equivalents The Company considers all highly liquid investments purchased with a maturity of three months or less on the date of purchase to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value. Under certain lease agreements and letters of credit, the Company has used cash and cash equivalents as collateral. There was $3.8 million of restricted cash related to such agreements at December 31, 2008 and 2007. Cash and Cash Equivalents The Company considers all highly liquid investments purchased with a maturity of three months or less on the date of purchase to be Under These excerpts taken from the THRX 10-K filed Feb 27, 2008. Cash and Cash Equivalents The Company considers all highly liquid investments purchased with a maturity of three months or less on the date of purchase to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value. Under certain lease agreements and letters of credit, the Company has used cash and cash equivalents as collateral. There was $3.8 million and $3.9 million of restricted cash related to such agreements at December 31, 2007 and 2006, respectively. 54 THERAVANCE, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) 1. Summary of Significant Accounting Policies (Continued) Cash and Cash Equivalents The Company considers all highly liquid investments purchased with a maturity of three months or less on the date of purchase to be cash equivalents. Cash Under 54 THERAVANCE, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued) 1. Summary of Significant Accounting Policies (Continued) This excerpt taken from the THRX 10-K filed Mar 1, 2007. Cash and Cash Equivalents The Company considers all highly liquid investments purchased with a maturity of three months or less on the date of purchase to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value. Under certain lease agreements and letters of credit, the Company has used cash and cash equivalents as collateral. There was $3.9 million of restricted cash and cash equivalents related to such agreements at December 31, 2006 and 2005. This excerpt taken from the THRX 10-K filed Mar 10, 2006. Cash and Cash Equivalents The Company considers all highly liquid investments purchased with a maturity of three months or less on the date of purchase to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value. Under certain lease agreements and letters of credit, the Company has used cash and cash equivalents as collateral. There was $3.9 million and $4.5 million of restricted cash and cash equivalents related to such agreements at December 31, 2005 and 2004, respectively. This excerpt taken from the THRX 10-K filed Mar 8, 2006. Cash and Cash Equivalents The Company considers all highly liquid investments purchased with a maturity of three months or less on the date of purchase to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value. Under certain lease agreements and letters of credit, the Company has used cash and cash equivalents as collateral. There was $3.9 million and $4.5 million of restricted cash and cash equivalents related to such agreements at December 31, 2005 and 2004, respectively. This excerpt taken from the THRX 10-K filed Mar 29, 2005. Cash and Cash Equivalents The Company considers all highly liquid investments purchased with a maturity of three months or less on the date of purchase to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value. Under certain lease agreements and letters of credit, the Company has used cash and cash equivalents as collateral. There was $4.5 million and $6.1 million of restricted cash and cash equivalents related to such agreements at December 31, 2004 and 2003 respectively. | EXCERPTS ON THIS PAGE:
RELATED TOPICS for THRX: |
| |||||||
